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Introduction
Rich lymphatic vessel (LV) networks supply the skin dermis 
and mucosal membranes covering major organs, including 
the respiratory tract, nasopharyngeal cavity, intestine, mes-
entery, diaphragm, heart, and lung. LVs are lacking or very 
sparse in bone, bone marrow, adipose tissue, heart myocar-
dium and skeletal muscles, and parenchymal tissues of brain, 
liver, kidney, and endocrine organs, such as the adrenal or 
thyroid gland. Presumably, these organs are devoid of LVs 
because of scarce interstitial fluid or the presence of an al-
ternative drainage system, such as fenestrated blood vessels 
(BVs). Interstitial fluid is drained into specialized blind-ended 
lymphatic capillaries, which connect and converge into grad-
ually larger collecting LVs and lymphatic ducts that empty 
into the subclavian vein. Lymphatic endothelial cells (LECs) 
of lymphatic capillaries are surrounded by a thin, discontin-
uous basement membrane, lack perivascular cells, and have 
discontinuous “button-like” cell junctions (Baluk et al., 2007). 
They readily sense changes in interstitial pressure via special-
ized anchoring filaments, which can modulate the opening 
of “flap valves” in-between the button junctions to allow 
fluid entry. It is also through these flap valves that immune 
cells enter lymphatic capillaries. Unidirectional lymph flow 
in collecting vessels is promoted by numerous intraluminal 
valves and coordinated contraction of LV smooth muscle 
cells (SMCs; Schulte-Merker et al., 2011; Sabine et al., 2016). 
LECs represent a distinct endothelial cell (EC) lineage, and 
LVs are frequently distinguished from BVs based on their 
expression of the transcription factor prospero homeobox-1 
(Prox1), transmembrane O-glycoprotein podoplanin (also 
known as gp38), vascular endothelial growth factor receptor 3 
(VEG FR3; also known as Flt4), neuropilin-2, and lymphatic 
vessel endothelial hyaluronan receptor-1 (LYVE1; Tammela 
and Alitalo, 2010; Alitalo, 2011; Aspelund et al., 2016).
LVs have traditionally been regarded as passive conduits 
for fluid and some immune cells, but this perspective has been 
enormously updated with the discovery of novel structures, 
origins, and functions of LVs in several organs. Organ-specific 
lymphatic capillary LECs display remarkable heterogene-
ity and plasticity, and acquire specialized functional proper-
ties adapted to the local microenvironment. Understanding 
organotypic LEC differentiation and function can help in 
designing more effective therapeutic and regenerative strat-
egies to cure a wider spectrum of common human diseases 
in which LVs have been shown to play major roles (Tam-
mela and Alitalo, 2010; Alitalo, 2011; Aspelund et al., 2016). 
Advances in general physiology and pathology, development, 
lymphedema, and tumor lymphangiogenesis are already cov-
ered by excellent recent reviews (Tammela and Alitalo, 2010; 
Alitalo, 2011; Mortimer and Rockson, 2014; Aspelund et al., 
2016; Dieterich and Detmar, 2016; Ulvmar and Mäkinen, 
2016; Potente and Mäkinen, 2017). In this review, we aim to 
summarize the latest results and their significance in under-
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standing organ-specific lymphatic vasculatures, and highlight 
the key characteristics and uniqueness of their structure and 
functions in development, homeostasis, and diseases.
Developmental origins of organ-specific LVs
Since the discovery of VEGF-C and its receptor, VEG FR3, 
as the key lymphangiogenic growth factor pathway and the 
transcription factor Prox1 as the master of LEC specifica-
tion, the development of lymphatic vasculature has been ex-
tensively studied and characterized in mouse and zebrafish 
models (Escobedo and Oliver, 2016; Venero Galanternik et 
al., 2016). The majority of LECs are produced by transdiffer-
entiation from venous endothelium, when a subpopulation 
of venous ECs expressing Prox1 is specialized into LECs (Es-
cobedo and Oliver, 2016; Venero Galanternik et al., 2016). 
Importantly, recent lineage-tracing studies highlighted an un-
expected diversity of LEC origins in several organs. In skin, 
cervical and thoracic LVs are formed by lymphangiogenic 
sprouting of Tie2-lineage+ venous-derived LEC progenitors 
(Martinez-Corral et al., 2015). In contrast, most lumbar LVs 
are formed via the process of coalescence and vessel net-
work formation (so-called lymphovasculogenesis) by isolated 
Tie2-lineage− nonvenous LEC progenitors. Although the he-
matopoietic origin of LECs in such clusters has been con-
clusively ruled out (Martinez-Corral et al., 2015), the precise 
precursor cell type remains to be established. Similarly, during 
cardiac development, a proportion of LECs in the heart was 
shown to descend from Tie2-lineage− nonvenous LEC pro-
genitors (Klotz et al., 2015). Moreover, mesenteric LVs orig-
inate from two distinct LEC sources: Tie2+ venous ECs and 
isolated EC clusters arising from PDG FB+ and c-Kit+ he-
mogenic ECs (Stanczuk et al., 2015). During lymph node 
(LN) development, all stromal cells, including LECs, have 
been suggested to arise from nestin+ precursors (Koning et 
al., 2016). Nestin is a marker of mesenchymal stem cells, but 
it is also expressed by a variety of other cells types, includ-
ing ECs; therefore, the precise origin of LN LECs remains 
to be fully investigated.
Prox1 and VEGF-C/VEG FR3/ADAM metallopep-
tidase with thrombospondin type 1 motif 3/collagen and 
calcium-binding EGF domains 1 are obligate molecular com-
ponents that define LEC fate and LV expansion in all organs; 
however, there are important organ-specific differences in 
downstream pathways. For example, blockade of PI3K signal-
ing, which acts downstream of activated VEG FR3, selectively 
affected the development of mesenteric, but not dermal, LVs 
(Stanczuk et al., 2015). Thus, the origins and heterogeneity 
of LECs in each organ are more diverse than previously ex-
pected, and further exciting findings on this topic are antici-
pated in the next decade.
Skin lymphatic vasculature
The skin is the body’s first line of defense against a hostile 
environment, including pathogens that can enter upon skin 
injury. Although the epidermis is avascular, the skin dermis is 
rich in BVs and LVs (Fig. 1 A). Dermal LVs are the main con-
duits for pathogens and immune cells from the periphery to 
draining LNs. They also play a major role in reverse cholesterol 
transport by transporting high-density lipoprotein-bound 
cholesterol from peripheral tissues to systemic blood circula-
tion to regulate cholesterol metabolism (Fig. 1 B; Lim et al., 
2013; Martel et al., 2013; Randolph and Miller, 2014). The 
migration rate of dendritic cells (DCs) and T lymphocytes 
via dermal afferent LVs is dramatically increased during the 
peak of inflammation (Fig. 1 C; Kim et al., 2014; Hunter et 
al., 2016). The majority of immune cells in the lymph of af-
ferent LVs are T cells (80–90%) and DCs (10–15%; Hunter et 
al., 2016). CD4+ T effector memory cells are the main subset 
that migrates via dermal afferent LVs at steady state, as well 
as in inflammation, and Foxp3+CD4+ regulatory T cells (T 
reg cells) constitute up to 25% of the intralymphatic T cell 
population (Brinkman et al., 2016; Hunter et al., 2016). Tis-
sue T reg cells are important regulators of dermal lymphatic 
function and repair LVs in inflammation and lymphedema 
(Gousopoulos et al., 2016); it is unclear whether T reg cells 
also contribute to maintaining normal LV integrity.
Cellular and molecular events during immune cell mi-
gration via dermal LVs have been extensively studied and re-
viewed (Randolph et al., 2017). C-C motif chemokine ligand 
21 (CCL21) produced by LECs is required for DC and T cell 
trafficking in skin LVs, and likely in most LVs of other or-
gans (Girard et al., 2012; Randolph et al., 2017). LECs secrete 
CCL21 abluminally and luminally, and extracellular CCL21 
gradients guide both recruitment and intraluminal directional 
crawling of DCs (Russo et al., 2016; Randolph et al., 2017). 
In addition, sphingosine-1 phosphate (S1P) signaling via S1P 
receptor 1 (S1PR1) regulates a T cell’s decision to egress or 
remain in tissue (Baeyens et al., 2015). It is unknown whether 
S1P production by dermal LECs is as important for regula-
tion of tissue lymphocyte egress as shown previously for LN 
LECs (Pham et al., 2010). Vascular cell adhesion molecule 1 
(VCAM-1), expressed by inflamed LECs, promotes T cell and 
DC entry into LVs (Brinkman et al., 2016; Randolph et al., 
2017; Teijeira et al., 2017). T reg cells produce especially high 
levels of lymphotoxin-α2β1, which engages lymphotoxin 
receptor-β on LECs to promote cell transmigration (Brink-
man et al., 2016). Subsequent intralymphatic T cell adhesion 
and crawling within capillaries are supported by intercellu-
lar adhesion molecule 1 (ICAM-1) on LECs and integrin 
lymphocyte function-associated antigen-1 on T cells (Teijeira 
et al., 2017). In addition to CCL21, C-X3-C motif chemo-
kine ligand 1 and C-X-C motif chemokine ligand 12 are 
secreted from LECs to guide DC and other innate immune 
cells trafficking into inflamed LVs (Fig. 1 C; Kabashima et al., 
2007; Johnson and Jackson, 2013). The spectrum of chemok-
ines and adhesion receptors produced by dermal LECs differ 
depending on the nature of inflammatory stimuli; for exam-
ple, ICAM-1, CXCL9, and CXCL10 are strongly induced in 
LECs in a contact hypersensitivity model, but not during in-
nate immune response elicited by complete Freund’s adjuvant 
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(Vigl et al., 2011). Such differential LEC responses are likely 
important for temporal coordination of tissue retention ver-
sus egress of specific immune cell populations during inflam-
mation. Lately, a novel role of LYVE1 in DC transmigration 
has been uncovered (Johnson et al., 2017). In inflamed der-
mal interstitium, DCs are coated with hyaluronan and interact 
with LYVE1 on lymphatic capillary LECs, mediating docking 
between the two cells within discrete “transmigratory cups” 
that envelop transiting DCs, thereby facilitating DC trans-
migration into LVs (Fig. 1 C; Johnson et al., 2017). Bacterial 
hyaluronic acid capsule interaction with LEC LYVE1 is also 
involved in the spread of a common skin-resident pathogen 
group A streptococcus (GAS) from the infection site to the 
regional draining LN (Fig. 1 C; Lynskey et al., 2015). Lym-
phatic spread of GAS can be detrimental for the host, as it 
causes lymphangitis and lymphadenitis. However, blocking 
LN accumulation of GAS in Lyve1−/− mice increased sys-
temic dissemination of bacteria in blood circulation (Lynskey 
et al., 2015), indicating that high levels LYVE1 on LECs may 
be important for pathogen containment.
Neutrophil egress into dermal LVs is minimal both in 
the steady-state condition and in sterile inflammation. How-
ever, during bacterial infection, neutrophils are the first to 
migrate from inflamed skin to draining LN, where they 
stimulate lymphocyte proliferation (Hampton et al., 2015). 
Neutrophil migration relies on lymphocyte function–asso-
ciated antigen 1, an integrin/complement receptor CD11b 
and C-X-C or C-C chemokine receptors CXCR4 and/or 
CCR7 (Fig. 1 C; Gorlino et al., 2014; Hampton et al., 2015; 
Arokiasamy et al., 2017). Dermis also contains an abundant 
population of macrophages, which contributes to local con-
trol of lymphangiogenesis and lymphatic remodeling during 
development, inflammation, and wound healing (Harvey 
and Gordon, 2012; Kim et al., 2014). In adult skin, macro-
phages play a unique role in the regulation of salt-sensitive 
hypertension: in response to increased local osmotic stress, 
skin macrophages activate nuclear factor of activated T cell 5– 
dependent production and secretion of VEGF-C (Fig. 1 C). 
The resulting expansion of cutaneous lymphatic network 
enhances interstitial electrolyte clearance, reduces peripheral 
tissue fluid pressure, and restores homeostasis (Machnik et al., 
2010; Wiig et al., 2013).
Lymphatic transport is important for normal skin ho-
meostasis and is implicated in multiple skin inflammatory 
diseases, including atopic and contact dermatitis and psori-
asis. The density and function of dermal LVs gradually re-
Figure 1. Organization and function of dermal lymphatic vasculature. (A) Skin LVs are organized in superficial and deep lymphatic plexuses. Super-
ficial LVs are mostly capillaries, whereas deep lymphatic plexus contain collecting LVs draining to the regional LNs. ECM, extracellular matrix. (B) CCR7+ 
CD4+ T cells, Langerhans cells (specialized skin DCs residing in epidermis), and DCs are the main immune populations trafficking via dermal LVs in response 
to CCL21 gradient produced by capillary LECs. Dermal macrophages sense tissue osmotic pressure and maintain tissue fluid homeostasis and systemic 
blood pressure by activating transcription factor NFAT5 and producing VEGF-C, which induces expansion of dermal LVs and enhances tissue clearance. 
LVs also play a major role in reverse cholesterol transport through recirculation of high-density lipoprotein (HDL)–bound cholesterol from the interstitial 
space. dLEC, dermal LEC. (C) During bacterial infection, neutrophils, extravasated from BVs, also migrate through LVs to LNs to enhance adaptive immune 
response. Inflamed LECs produce adhesion receptors, such as VCAM-1 and ICAM-1, and chemokines (e.g., CXCL12) that enhance the attraction, adhesion, 
and intralymphatic crawling of immune cells. Lymphatic capillary hyaluronan receptor LYVE1 mediates interaction of LECs with hyaluronan-coated DCs and 
with the hyaluronan-containing capsule of some skin bacterial pathogens, such as GAS.
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duces with age, which may contribute to the development of 
age-related skin disorders (Karaman et al., 2015). Impairment 
of dermal LV function leads to lymphedema, hyperpigmen-
tation, keratosis, and papillomatosis (Carlson, 2014). Studies 
of animal models of chronic skin inflammation demonstrated 
that blocking LV expansion exacerbates the disease, whereas 
stimulation of lymphangiogenesis by VEGF-C administration 
reduces it (Huggenberger et al., 2010).
Meningeal lymphatic vasculature
The brain parenchyma lacks LVs and instead has an alternative 
but essential fluid drainage system, the so-called glymphatic 
system (Iliff et al., 2012). The glymphatic system is named for 
its dependence on glial cells for a draining function similar to 
the lymphatic system. The glymphatic system promotes waste 
clearance from the brain by expediting the flux of cerebrospi-
nal fluid across the brain parenchyma, which is ∼60% more 
efficient during sleep (Iliff et al., 2012). However, recent re-
discovery of the mouse brain meninges lymphatic networks 
raised exciting questions and intriguing concepts (Aspelund 
et al., 2015; Louveau et al., 2015), and similar structures were 
also found in autopsy specimens of human meninges (Absinta 
et al., 2017). Importantly, high-resolution, clinical magnetic 
resonance imaging technique has enabled the visualization of 
human meningeal lymphatic networks (Absinta et al., 2017). 
In fact, the existence of lymphatic vasculature on the sur-
face of the human brain had been proposed two centuries 
ago and displayed in anatomical wax model collections (the 
Josephinum Wax Models Museum, Vienna, Austria; Lukić et 
al., 2003), but it has been mostly ignored. Most meningeal 
LVs are located on the meningeal layer (also called “dura 
mater”) and are phenotypically similar to lymphatic capillar-
ies in other organs (Fig. 2; Aspelund et al., 2015). However, 
valves are present only in LVs near the base of the skull along-
side the cranial nerves. Activation of VEG FR3 by VEGF-C 
increases the diameter of meningeal LVs, and blocking 
VEG FR3 signaling completely abrogates meningeal LVs, in-
dicating that these vessels, like peripheral LVs, are regulated 
by VEG FR3 (Aspelund et al., 2015). A recent study (Antila et 
al., 2017) demonstrated that VEGF-C–VEG FR3 signaling is 
crucial not only for development but also for maintenance of 
meningeal LV integrity during adulthood. Functionally, some 
cerebrospinal fluid and interstitial fluid of brain parenchyma 
flow through glymphatic system, drain into meningeal LVs, 
and reach the deep cervical LNs. Intriguingly, a significant 
decline in cerebrospinal fluid outflow via meningeal LVs was 
observed in aged mice (Ma et al., 2017), implying that menin-
geal lymphatic networks could be targeted for age-associated 
neurological conditions. Further research is required to map 
out the connections among this newly uncovered lymphatic 
circuit, the glymphatic system, and the rest of the lymphatic 
circuitry throughout the body (Louveau et al., 2017). It 
would also be intriguing to determine whether cerebrospinal 
fluid drainage into meningeal LVs also increases during sleep. 
Moreover, it is reasonable to speculate that impairment in this 
lymphatic circuit could be related to brain edema, which is 
often detected during ischemia, concussions, inflammation, 
and brain tumors. Furthermore, it will be important to es-
tablish whether meningeal LVs are involved in the clearance 
of amyloid β and other misfolded proteins from the brain 
parenchyma, which are frequently and highly accumulated in 
patients with neurodegenerative diseases such as Alzheimer’s 
and Parkinson’s diseases.
The brain has also been regarded as an immune-privileged 
organ, in part because of the dearth of LVs. It was thought 
that infiltrated T cells in the brain exit through venous rather 
than lymphatic circulation, which is the case in all other or-
gans (Ransohoff and Engelhardt, 2012). However, a large 
population of T cells was observed in the lumen of meningeal 
LVs, raising the intriguing possibility of an alternative gate-
way for T cells to egress from the brain to the deep cervical 
LNs (Louveau et al., 2015). Dissecting the lymphatic route 
for brain-resident T cells will advance our understanding of 
the communication between the central nervous system and 
the immune system and unveil new therapeutic targets for 
inflammatory neurological disorders, including encephalo-
myelitis and multiple sclerosis (Louveau et al., 2017). Another 
question requiring further investigation is whether meningeal 
LVs can act as a route for brain cancer metastasis. Thus, the 
rediscovery of meningeal LVs reveals new concepts regarding 
brain functions and diseases.
Brain mural LECs (muLECs)
In 2017, three research groups (Bower et al., 2017; van Lessen 
et al., 2017; Venero Galanternik et al., 2017) independently 
identified a novel population of isolated muLECs (also called 
mannose receptor-1+ perivascular cells) surrounding men-
ingeal BVs using transgenic zebrafish models (Fig.  2). The 
muLECs express LEC markers such as LYVE1 and Prox1, 
and a perivascular macrophage marker, mannose receptor-1, 
but, unlike all other ECs, they do not form a lumenized vessel. 
muLECs are uniquely found on the inner side of the meninx, 
adjacent to the brain parenchyma. They originate from the 
lymphatic endothelium in the midbrain or the optic choroidal 
vascular plexus by sprouting lymphangiogenesis during brain 
development, and differentiate into a dispersed, nonlumenized 
mural lineage. Similar to other LECs, muLEC development 
requires signaling through the VEGF-C–VEGF-D–collagen 
and calcium-binding EGF domains 1–VEG FR3 pathway. 
Mature muLECs are relatively large mural cells that produce 
vascular growth factors and accumulate low-density lipopro-
teins from the bloodstream. Although muLECs seem to be 
important for meningeal vascularization, they are dispens-
able for the maintenance of vessel integrity. These studies 
identified a novel lymphatic lineage that differentiates into 
mural cell-like cells that are necessary for establishing normal 
meningeal blood vasculature, and have raised the possibility 
that an equivalent cell type exists in the mammalian brain 
(Bower et al., 2017; van Lessen et al., 2017; Venero Galan-
ternik et al., 2017). Although the three groups did not have 
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the same consensus opinion, it is tempting to speculate that 
muLECs may be the equivalent of lipid-laden cells, perivas-
cular macrophages, fluorescent granular perithelial cells, or 
‘Mato Cells’ (Mato et al., 1981, 1996; Williams et al., 2001) 
that take up lipids and low-density lipoproteins from men-
ingeal BVs in mammals. In fact, muLECs become elongated 
and accumulate a larger amount of lipid droplets after acute 
high-cholesterol diet. Moreover, they are able to take up and 
clear macromolecules through mannose receptors (van Lessen 
et al., 2017; Venero Galanternik et al., 2017). Further compar-
ative investigation between fish and mammals is required to 
understand the roles and significance of muLECs.
Schlemm's canal (SC): Lymphatic 
intermediate and glaucoma
SC is an endothelium-lined channel that encircles the cornea 
and provides unique vascular route for aqueous humor out-
flow, which constantly refreshes the anterior chamber of eye 
(Fig. 3 A). Aqueous humor, continuously produced by the 
ciliary body, flows into the anterior chamber, and is drained 
into the aqueous and episcleral veins through trabecular mesh-
work and SC. SC has morphological, molecular, and functional 
similarities with LVs. In 2014, several independent research 
groups (Aspelund et al., 2014; Kizhatil et al., 2014; Park et 
al., 2014; Truong et al., 2014) found that SC represents a new 
intermediate vessel type, which expresses LEC markers Prox1, 
VEG FR3, and integrin α9, but not LYVE1 and podoplanin. 
The primitive SC is formed by blood ECs sprouting from 
the choroidal vein, and SC ECs are postnatally respecified 
to acquire lymphatic phenotypes through up-regulation of 
Prox1, which also appears to act as a molecular biosensor for 
aqueous humor outflow (Park et al., 2014). Importantly, Tie2 
is expressed before Prox1 in SC ECs and is maintained at a 
high level to critically regulate SC integrity during adulthood 
Figure 2. Meningeal lymphatic vasculature and brain mural LECs. Localization and distribution of LVs in dura matter of mouse brain. Cerebrospinal 
fluid (CSF) and interstitial fluid of brain parenchyma drain into meningeal LVs and reach the deep cervical LNs. Trafficking of brain immune cells, including T 
cells, DCs, and macrophages, and clearance of neurotoxic misfolded proteins and peptides, such as amyloid β, are among the potential important functions 
of meningeal LVs. A unique, LV-derived population of muLECs surrounding brain BVs was recently found in zebrafish. muLECs express Prox1, LYVE1, and 
mannose receptor 1 (MR1), and are highly endocytotic. Unlike all other EC, muLECs do not form cell–cell junctions or lumenized structures. Whether muLECs 
are equivalent to perivascular Mato cells (LYVE1+, Prox1−, MR1+, and lipid droplet+), found in mammalian brain, remains to be established. Perivascular Mato 
cells are also detected in surrounding meningeal LVs.
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(Kim et al., 2017). Thus, SC ECs seem to originate from Tie2+ 
venous EC progenitors (Aspelund et al., 2014; Kizhatil et al., 
2014; Park et al., 2014). Another important regulator of SC is 
VEGF-C/VEG FR-3 signaling, which is critical for the forma-
tion and differentiation of SC. Surprisingly, supplementation 
of VEGF-C can also induce SC growth in adults, leading to a 
reduction of intraocular pressure in the aged glaucoma model 
(Aspelund et al., 2014).
Aqueous humor is rapidly drained transcellularly 
through SC ECs causing formation of giant vacuoles (Fig. 3, 
B and C). When SC is impaired, aqueous humor drainage 
is impeded and intraocular pressure is increased, ultimately 
leading to glaucoma (Jonas et al., 2017). In this regard, glau-
coma induced by defective SC could also be regarded as 
‘eye lymphedema’. However, the pathogenesis involving SC 
defects in glaucoma is still poorly understood. Intriguingly, 
primary congenital glaucoma phenotypes were detected in 
mouse models of double Angpt1/Angpt2 deletions or Tie2 
deletion during postnatal periods, highlighting the impor-
tance of the angiopoietin (Angpt)-Tie2 system in SC de-
velopment (Thomson et al., 2014). In fact, Tie2 mutations 
have been identified in patients with primary congeni-
tal glaucoma (Souma et al., 2016). Nevertheless, although 
the incidence rate of primary congenital glaucoma is low, 
primary open-angle glaucoma is frequently observed in 
the elderly. A recent study (Kim et al., 2017) showed that 
double Angpt1/Angpt2 deletions or Tie2 deletion in adult 
mice severely impairs SC integrity and transcellular aque-
ous humor fluid transcytosis, leading to elevated intraocular 
pressure, retinal neuron damage, and impairment of retinal 
ganglion cell function, which are all hallmarks of primary 
open-angle glaucoma. Accordingly, Tie2 reactivation using a 
Tie2 agonistic antibody relieved the phenotype in double 
Angpt1/Angpt2-deleted mice and rejuvenated the SC in 
aged mice (Kim et al., 2017). These findings provide not only 
a novel molecular pathway in understanding pathogenesis of 
primary open-angle glaucoma but also a new therapeutic 
avenue for its treatment.
Figure 3. Schlemm's canal. (A) SC is an endothelium-lined channel that encircles the cornea and provides an exit route for aqueous humor. (B) Aqueous 
humor is produced from the ciliary body and drained into aqueous and episcleral veins through the trabecular meshwork and SC. (C) Aqueous humor is 
drained transcellularly and transported from the basal to luminal side through SC ECs, causing formation of giant vacuoles. SC ECs have an intermediate 
blood-lymphatic EC phenotype and express Prox1, VEG FR3, Tie2, and integrin α9, but not LYVE1 or podoplanin. Angpt1+ stromal cells adjacent to the SC LECs 
may produce proteins of trabecular meshwork. When SC function is impaired, aqueous humor drainage is impeded and intraocular pressure is increased, 
ultimately leading to glaucoma. Angpt–Tie2 signaling maintains SC integrity, and loss of such signaling induces primary congenital and open-angle glau-
coma. AHO, aqueous humor outflow; E & A vein, episcleral & aqueous vein; VEC, venous endothelial cell.
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Sinusoidal LVs in LNs
LNs are highly dynamic secondary lymphoid organs where 
antigens, together with costimulatory signals, are delivered 
by afferent LVs (Fig. 4 A). LN LVs are extended lymphatic 
networks from peripheral afferent LVs, which continue to 
form the subcapsular sinus (SCS), stretch into the medullary 
sinus, and ultimately exit as efferent LVs. LVs traverse through 
densely packed aggregations of immune cells, predominantly 
B and T cells and such architecture facilitates intimate in-
teraction between LN LVs and immune cells, directly influ-
encing immune responses. Thus, LN LVs efficiently transport 
antigens and innate immune cells from various organs to 
naive lymphocytes in LNs, which is one of the crucial steps 
for the initiation and regulation of adaptive immune response 
as well as for the maintenance of immune tolerance (Junt et 
al., 2008; Randolph et al., 2017). During the acute phase of 
local tissue inflammation, robust lymphangiogenesis, stimu-
lated by VEGF-A, C and D secreted from infiltrated, activated 
macrophages, occurs in the draining LN, and subcapsular LN 
LVs proliferate and penetrate deep into the cortex (Kataru 
et al., 2009). In this situation, activated B cells also contrib-
ute to LN lymphangiogenesis to promote dendritic cell (DC) 
mobilization from the inflamed tissue to LN (Angeli et al., 
2006). As shown in helminth infection model, VEGF-A and 
VEGF-C production by B cells and mesenteric LN lymph-
angiogenesis relies on lymphotoxin-dependent feed-forward 
cross-talk of B-cells and surrounding follicular reticular cells 
(Dubey et al., 2017). Interferon-γ secreted from activated T 
cells can be a negative but balancing regulator that suppresses 
LN lymphangiogenesis during inflammation resolution 
(Kataru et al., 2011).
LN LECs produce several factors that regulate leuko-
cyte trafficking, delivery of inflammatory signals, modulation 
of T cell activation, and development of secondary lymphoid 
organs. LECs regulate the exit of immune cells via efferent 
LVs by secreting S1P, generated by sphingosine kinases with 
the S1P lyase enzyme, creating an S1P gradient important 
for immune cell egress through efferent LVs (Fig. 4 A; Pham 
et al., 2010). In addition to its role in T cell trafficking, LN 
LEC-derived S1P promotes naive T cell survival by sustaining 
their mitochondrial function and oxidative phosphorylation 
(Mendoza et al., 2017). Integrin α9β1 on LECs is also neces-
sary for LN lymphocyte egress, and the interaction between 
integrin α9β1 and its ligand tenascin-C has been shown to 
enhance the production of S1P by LECs (Ito et al., 2014). LN 
LECs are also an important source of interleukin-7, critical for 
lymphocyte expansion during LN remodeling (Onder et al., 
2012). Interleukin-7 expression by LECs also provides a niche 
for memory T-helper cells in inducible bronchus-associated 
lymphoid tissues during allergic inflammation in lung (Shi-
noda et al., 2016). LN LECs produce immunosuppressive 
factors, such as TGF-β, indoleamine-2,3-dioxygenase, and 
nitric oxide to maintain peripheral tolerance to self-antigen 
in lymph (Fig.  4  B; Lukacs-Kornek et al., 2011; Malhotra 
et al., 2012). Of note, LN LECs directly express peripheral 
tissue antigens and induce deletional tolerance in CD8+ T 
cell via PD-1–PD-L1 or LAG-3–MHC-II pathways (Rou-
hani et al., 2015). Moreover, a subset of LECs was shown to 
provide antigens to DCs, which then induced CD4+ T cell 
anergy (Rouhani et al., 2015). On the other hand, Dubrot et 
al. (2014) also reported that LECs can acquire preloaded pep-
tide–MHC-II complexes from DCs to induce CD4+ T cell 
tolerance. Overall, LN LECs play multiple tolerogenic roles 
against self-antigens by directly presenting a variety of pe-
ripheral tissue antigens for CD8+ T cell deletional tolerance, 
whereas they also induce CD4+ T cell tolerance via antigen 
transfer to or from DCs (Fig. 4 B).
Tumors produce lymphangiogenic growth factors, 
tumor antigens, and premetastatic signals to tumor draining 
LNs even before LN metastasis (Karaman and Detmar, 2014; 
Ogawa et al., 2014; Dieterich and Detmar, 2016). COX-2/
PGE2-EP3–dependent induction of VEGF-C and VEGF-D in 
macrophages and DCs induces tumor-induced LN lymphan-
giogenesis (Ogawa et al., 2014). Interestingly, LECs of tumor 
draining LNs are capable of scavenging and cross-presenting 
tumor antigens, which induce dysfunction of CD8+ T cells 
(Lund et al., 2012). Tumor and tumor draining LN–derived 
VEGF-C promotes these processes and accelerates metastasis 
(Lund et al., 2012). In addition to follicular DCs, proliferat-
ing SCS LECs can capture or act as a reservoir for persistent 
viral antigens, contributing to the development of an effective 
memory CD8+ T cell pool with increased effector function 
and protective capacity (Fig. 4 B; Tamburini et al., 2014). This 
beneficial role of LN LECs can be exploited to improve effi-
cacy of vaccines against viral infections.
SCS LECs and medullary sinusoidal LECs have distinct 
features including cellular organization, expression profiles, 
roles, and responses to inflammation (Fig.  4  A; Iftakhar-
E-Khuda et al., 2016). For instance, macrophage scavenger 
receptor 1 is selectively expressed by SCS LECs and regulates 
the binding and transmigration of lymphocytes entering from 
peripheral tissues into LN parenchyma, whereas endomucin 
produced by medullary sinusoidal LECs presumably regu-
lates lymphocyte trafficking via L-selectin (Iftakhar-E-Khuda 
et al., 2016). Medullary sinusoidal LECs also produced the 
highest levels of peripheral tissue antigens and PD-L1 and 
therefore play a key role in the deletion of alloreactive CD8+ 
T cells (Cohen et al., 2014). SCS LECs, but not peripheral 
LECs, express plasmalemma vesicle-associated protein (also 
known as MECA-32; Rantakari et al., 2015). The SCS floor 
allows the entrance of only small (<70 kD and <4 nm) sol-
utes, which are then rapidly transported through the LN pa-
renchyma to BVs by conduits, a specialized tubular meshwork 
formed by extracellular matrix from follicular reticular cells. 
Plasmalemma vesicle-associated protein plays a central role 
in such selective barrier function of subcapsular sinusoids by 
forming molecular “sieves” or diaphragms covering transen-
dothelial channels in SCS LECs, which then prevents the 
passage of larger solutes to follicular reticular cell conduits 
(Fig. 4 A; Rantakari et al., 2015).
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A substantial degree of specialization is also present 
in the SCS LECs, where LECs facing the LN capsule (or 
“ceiling” LECs) express high levels of a CCL21/CCL19 
decoy chemokine receptor CCRL1. Polarized CCRL1 ex-
pression creates a CCL21 gradient, allowing the directional 
DC migration into the LN paracortex to reach T cells 
(Ulvmar et al., 2014). Ceiling LECs are LYVE1 negative 
and also produce CCL1 chemokine (Das et al., 2013), 
whereas floor LEC are LYVE1 positive. The floor LEC layer 
is interspersed with CD169+ SCS macrophages, which take 
up antigens and pathogens (Fig. 4 A). Interestingly, although 
DCs are able to transmigrate directly through the floor 
of the SCS, naive T cells use the medullary sinus to reach 
LN parenchyma; however, transmigrating DCs also induce 
structural alterations in the SCS floor, which allows sub-
sequent homing of T cells through the SCS (Braun et al., 
2011). Onder et al. (2017) recently highlighted a new role 
of LECs in LN formation. Different from the prevailing LN 
formation model (Mebius, 2003; van de Pavert and Mebius, 
2010), this study reports that that initiation of LN devel-
opment requires lymphoid tissue inducer cell-mediated 
activation of LECs and that the engagement of mesenchy-
mal stromal cells is a subsequent event. Mechanistically, LN 
initiation is mediated mainly through receptor activator 
of the NF-κB signaling–noncanonical NF-κB pathway in 
LVs and is driven by CCL21 and S1P receptor–dependent 
retention of lymphoid tissue inducer cells in the LN an-
lage (Onder et al., 2017).
Figure 4. LN lymphatic vasculature. (A) Afferent LVs deliver lymph carrying antigens and immune cells to the LN SCS. From the SCS, lymph flows to the 
cortical and medullary sinuses and exits via efferent LVs. SCS “ceiling” LECs (cLECs) express the decoy CCL19/CCL21 receptor CCRL1, which creates a gradient 
of CCL21 enhancing transmigration of DCs into T zones. CD169+ SCS macrophages inserted in the “floor” LEC (fLEC) layer take up antigens and pathogens. 
The majority of lymph drains via LN LVs, whereas a proportion of small solutes is absorbed from lymph via specialized conduits, a network of collagen fibrils, 
surrounded by follicular reticular cells. Molecular diaphragms formed by plasmalemma vesicle-associated protein restrict access of larger substances into 
conduits. Similar to fLECs, medullary sinus LECs are in close contact with macrophages, which clear pathogens and antigens. S1P produced by medullary and 
cortical sinuses LECs induces egress of lymphocytes into efferent LVs and promotes T cell survival. (B) Specialized functions of LN LECs. LN LECs contribute 
to maintenance of tolerance against self-antigens through the expression of peripheral tissue antigens and deletion of self-reactive CD8+ T cells. LN LECs 
can tolerize CD4+ cells either by transferring peptide–MHC-II complexes to DCs or acquiring them from DCs. LN LECs also produce immunosuppressive nitric 
oxide (NO) and indoleamine-2,3-dioxygenase (IDO1), which restrains proliferation of activated T cells. During acute viral infection, proliferating LN LECs 
uptake and store viral antigens. During the LN contraction stage, such antigens are transferred by dying LECs to DCs, which cross-present them to T cells to 
promote CD8+ T cell memory responses. Ag, antigen; FRC, follicular reticular cell; PLV AP, plasmalemma vesicle–associated protein.
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Lacteals and lymphatic vasculature in the small intestine
In addition to the common task of all LVs in transporting 
interstitial fluid and immune cells, the intestinal lymphatic 
vasculature plays a major role in the uptake and transport 
of dietary fat. In mammals, dietary lipids are repackaged in 
enterocytes into large (200–1,000 nm) triglyceride-loaded 
particles or “chylomicrons,” which are secreted basally into 
intestinal stroma. In addition to triglycerides, chylomicrons 
can also incorporate fat-soluble vitamins and drugs, as well 
as some microbiota components, such as bacterial lipopoly-
saccharides (Bernier-Latmani and Petrova, 2017). The single 
lymphatic capillary located at the center of each small intes-
tinal villus, called a lacteal, takes up chylomicrons and other 
interstitial fluid components from villi and transports them 
to the submucosal and mesenteric collecting LVs (Fig. 5, A 
and B). The lymphatic vascular plexus, located in the intes-
tinal muscular layer, drains independently to the mesenteric 
collecting LVs. Intestinal lymph is transported to the mes-
enteric LNs and thoracic duct and is subsequently released 
into the blood circulation (Fig. 5 A). Through these transport 
processes, lipid-soluble drugs can directly access the target or-
gans while bypassing the liver, where most of drugs are de-
graded (Trevaskis et al., 2015). The mechanism and selectivity 
of chylomicron uptake into lacteals are not entirely clear 
and may involve both intercellular transport through LEC 
junctions and intracellular transport across LECs in vesicles 
(Bernier-Latmani and Petrova, 2017). Periodic squeezing of 
lacteals, which is mediated by the contraction of surround-
ing longitudinal smooth muscle cells in intestinal villi con-
trolled by the autonomic nervous system, allows efficient 
drainage of absorbed lipids into the collecting vessel net-
work (Choe et al., 2015).
Although the majority of adult LVs are quiescent, in-
testinal lacteals exhibit low but detectable proliferation under 
Figure 5. LVs of the small intestine. (A) Intestinal lacteals are positioned in the middle of intestinal villi. Smooth muscle cells in the villi are closely 
associated with lacteals, and their contractions promote lymph uptake and transport. Another lymphatic vascular plexus is located in the intestinal muscular 
layer. Lymph from both plexuses is drained to mesenteric collecting vessels, mesenteric LNs, and the thoracic duct and returned to the blood circulation. 
(B) Intestinal lacteals transport chylomicrons, cholesterol, gut hormones, and immune cells. Lymphatic trafficking of CD103+ DCs carrying food antigens 
and apoptotic intestinal epithelial cells to mesenteric LN drives the development of T reg cells and tolerance. The role of LVs trafficking in intestinal ILC3 
function is not understood. (C) Role of villus SMCs in the maintenance of intestinal LVs. VEGF-C, produced by villus SMCs, and VEGF-C–dependent DLL4 
signaling in LECs fuel continuous lacteal regeneration. Periodic contraction of villus SMCs, controlled by the autonomic nervous system, promotes lymph 
transport. Ag, antigen; IEC, intestinal epithelial cell; TD, thoracic duct.
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steady-state conditions and frequently harbor filopodia, in-
dicating an ongoing lymphangiogenic response (Bernier- 
Latmani et al., 2015; Bernier-Latmani and Petrova, 2016). 
Mechanistically, maintenance of lacteal integrity and fat trans-
port function requires continuous Notch and VEGF-C–VEG 
FR-3 signaling, with VEGF-C being supplied by the sur-
rounding smooth muscle cells (Fig. 5 C; Bernier-Latmani et 
al., 2015; Nurmi et al., 2015). Lacteals are characterized by a 
mix of both continuous zipper junctions and discontinuous 
button-like junctions, and loss of Notch signaling impairs the 
formation of mature button-like junctions (Bernier-Latmani 
et al., 2015). Optimal junctional organization and transport 
function of lacteals also require adrenomedullin-calcitonin 
receptor signaling; lymphatic-specific inactivation of calci-
tonin receptor results in intestinal lymphangiectasia and pro-
tein-losing enteropathy (Davis et al., 2017). Identification of 
the specific lacteal transcriptome will be important to further 
understand the molecular mechanisms underlying the func-
tional specialization of lacteals.
The intestine harbors a large population of immune cells 
whose task is to maintain and fine-tune the balance between 
immune tolerance to the myriad of commensal intestinal bac-
teria and ingested harmless antigens and responses against po-
tential pathogens. Similar to other tissues, CCR7-expressing 
DCs migrate into intestinal lymphatics in response to the 
CCL21 gradient generated by LECs. The transport of food 
antigens by CD103+ DCs to mesenteric LNs appears to be 
a key step in the establishment of oral tolerance through the 
induction of mesenteric LN T reg cells (Pabst and Mowat, 
2012). Production of such T reg cells is also maintained by 
lymphatic trafficking of DCs after ingestion of apoptotic in-
testinal epithelial cells, which are continuously produced as 
a result of rapid intestinal epithelium turnover (Cummings 
et al., 2016). The CCR7+Rorgt+ subset of intestinal innate 
lymphoid cells also egresses via intestinal LVs to mesenteric 
LNs, but the functional significance of such transport requires 
further investigation (Fig. 5 B; Mackley et al., 2015). Given 
the importance of T cell trafficking via dermal LVs, it would 
also be interesting to characterize lymphatic transport of in-
testinal T cell subsets.
The role of LVs in intestinal pathological states, for ex-
ample in inflammatory bowel disease (IBD), is attracting in-
creasing attention (von der Weid et al., 2011; Bernier-Latmani 
and Petrova, 2017). Increased lymphangiogenesis and lym-
phatic vascular dysfunction, such as lymphangiectasia and 
intralymphatic lymphocyte stasis, have long been described 
as pathological features of Crohn’s disease (von der Weid et 
al., 2011). Data from animal models suggest that damage to 
lymphatic vasculatures and its unproductive expansion may 
be contributing or perhaps even initiating factors in IBD 
(Bernier-Latmani and Petrova, 2017). Diphtheria toxin–me-
diated conditional ablation of LVs in the intestine leads to 
rapid animal demise because of extreme disruption to the in-
testinal mucosal barrier and septic shock (Jang et al., 2013). 
Furthermore, impaired intestinal lymphatic vascular func-
tion or lymphangiogenic response exacerbates intestinal in-
flammation and worsens symptoms in experimental models 
of colitis (von der Weid et al., 2011; D’Alessio et al., 2014; 
Davis et al., 2017). Mice deficient in D6 decoy chemokine 
receptor, which is highly expressed by LECs and is neces-
sary to restrict aberrant inflammatory leukocyte adhesion to 
LVs, develop more severe colitis, further underscoring a major 
role of LVs in resolution of intestinal inflammation (Vetrano 
et al., 2010; McKimmie et al., 2013). Conversely, even tran-
sient inflammation during acute intestinal infection has been 
shown to induce a long-lasting damage of LV function and 
gut immunity, suggesting that cumulative immunological 
scarring of intestinal LVs could underlie the development of 
IBD (Fonseca et al., 2015). In contrast, prolymphangiogenic 
therapy using adenoviral delivery of VEGF-C markedly re-
duces disease severity (D’Alessio et al., 2014). Further studies 
of molecular characteristics of intestinal lymphatic endothe-
lium in homeostasis and diseases, together with identification 
of immune cell subsets that travel via LVs, will be import-
ant to better understand the mechanisms behind responses 
against pathological insults.
Perspectives and open questions
The discovery of lymphatic-specific molecular markers, 
growth factors and their receptors, and transcription factors 
transformed the field of lymphatic vascular biology and laid 
the foundations for further conceptual advances in under-
standing the mechanisms and functions of organotypic lym-
phatic vasculatures. Many questions are emerging in this 
rapidly developing field, some of which are outlined below.
Efficient in vitro LEC fate programming for tissue engi-
neering. All tissue regeneration procedures, from wound 
healing to transplantation of engineered organs, demand ad-
equate vascularization by both BVs and LVs. Therefore, reli-
able methods for the in vitro production of LECs will likely 
improve the outcomes. Prox1 overexpression partially re-
programs mature blood ECs toward the LEC lineage, and 
several stimuli, such as retinoic acid, WNT, or constitutively 
active ERK signaling, facilitate acquisition of LEC pheno-
type (Marino et al., 2011; Deng et al., 2013; Bowles et al., 
2014; Nicenboim et al., 2015). Furthermore, generation of 
fully differentiated LECs from human pluripotent stem cells 
is feasible (Lee et al., 2015). However, unlike for blood ECs 
(Orlova et al., 2014), questions regarding the best combina-
tion of transcription factors, extracellular inputs, and intra-
cellular signaling cascades for driving LEC fate commitment 
still require definitive answers.
Degree and functional significance of LEC heterogeneity. The 
discovery of the developmental heterogeneity of LECs has 
raised several further questions. What are the origins of LECs 
in other organs, and what is the reason for the existence of 
multiple LEC sources? Can LECs of different origins be dis-
tinguished in mature vessels, and do such LECs participate 
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equally in the growth and expansion of LVs during inflam-
mation and regeneration? Single-cell sequencing approaches 
have already provided a host of important insights into the 
heterogeneity and population dynamics of immune and can-
cer cells (Papalexi and Satija, 2017); therefore, it is anticipated 
that the application of this methodology to LECs will open 
new perspectives for high-resolution mapping of LEC sub-
populations in different organs and associated phenotypes.
Organ-specific lymphangiocrine signaling. BVs not only de-
liver oxygen and nutrients to tissues but also produce tis-
sue-specific molecules that participate in organ repair and 
regeneration (Rafii et al., 2016; Augustin and Koh, 2017; Po-
tente and Mäkinen, 2017). LECs are also capable of secreting 
distinguishable molecules, including growth factors, cyto-
kines, and chemokines, which are defined as “lymphangioc-
rine” molecules. Most of such lymphangiocrine signals to 
date have been linked to the regulation of immune responses, 
especially in LNs (e.g., S1P, which promotes migration and 
survival of T cells). Identifying lymphangiocrine molecules in 
other organs and understanding how they contribute to the 
organ-specific function are essential future tasks to accomplish.
Maintenance of organ-specific differentiation. The transcrip-
tional profiles of cultured human intestinal LECs differ from 
those of dermal LECs, indicating that some organ-specific fea-
tures are conserved in vitro (Norrmén et al., 2010). However, 
standard cell culture conditions introduce significant biases 
when analyzing the specialized phenotypes of ECs. Analyses 
and comparisons of various “omics” of LECs isolated (1) from 
different organs, (2) at different stages of development, and (3) 
during tissue regeneration or in pathological conditions will 
undoubtedly be useful when characterizing their organotypic 
properties and identifying tissue-specific markers of LVs and 
the mechanisms for their maintenance. The current boom in 
the development of “organ-on-chip” devices will provide an 
important new opportunity for modeling and studying hetero-
typic interactions of LECs with other tissue components, in-
cluding various epithelia, immune cell populations, and 
microbiota products.
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